Astellas Pharma Inc. (TYO:4503)
Japan · Delayed Price · Currency is JPY 2,484.50
-117.00 (-4.50%)
At close: Mar 2, 2026
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of 4.45 trillion as of March 2, 2026. Its market cap has increased by 64.15% in one year.
Market Cap
4.45T
Enterprise Value
4.92T
Revenue
2.06T
Ranking
n/a
PE Ratio
13.87
Stock Price
2,484.50
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 4.45T, an increase of 404.09%. That is a compound annual growth rate of 4.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 4.66T | 24.30% |
| Dec 30, 2025 | 3.75T | 36.48% |
| Dec 30, 2024 | 2.75T | -9.13% |
| Dec 29, 2023 | 3.02T | -17.34% |
| Dec 30, 2022 | 3.66T | 5.52% |
| Dec 30, 2021 | 3.47T | 17.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 17.21T |
| Daiichi Sankyo Company | 5.66T |
| Otsuka Holdings | 5.66T |
| Kyowa Kirin | 1.51T |
| Ono Pharmaceutical | 1.26T |
| Santen Pharmaceutical | 562.44B |
| JCR Pharmaceuticals | 84.66B |
| Perseus Proteomics | 3.45B |